RCE 0.97% 52.0¢ recce pharmaceuticals ltd

Ann: Phase I Clinical Trial R327 Advances to High Dose Cohort, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 206 Posts.
    lightbulb Created with Sketch. 197
    Weird share price action... the more progress there is, the more the share price drops. Can't have been too many times this has happened with a biotech company. By the time we get a successful 16 000 mg dose the share price should be at zero. That is after my wife told me a company that has a product that can kill just about any bacteria would be worth billions!!! I'm considering buying more, but I'm a bit over-extended into this already.

    I checked a while back the price of the antibiotic treatment against sepsis that RCE was comparing their rat tests with. It appeared to be around $3000 per treatment(USD). RCE 327 seemed to work better in rats(survival rate 100%) than the other antibiotic treatment. It means there should be some money to be made with a better product. The share price is just not reflecting this. I'm perplexed to say the least.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
52.0¢
Change
0.005(0.97%)
Mkt cap ! $120.5M
Open High Low Value Volume
54.0¢ 54.0¢ 52.0¢ $4.485K 8.497K

Buyers (Bids)

No. Vol. Price($)
1 17 52.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.0¢ 14897 2
View Market Depth
Last trade - 15.47pm 04/10/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.